KIAA1984 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the KIAA1984 protein, also referred to as DIS3L2, which belongs to the exosome-associated family of ribonucleases. This protein plays a crucial role in regulating RNA stability and degradation, contributing to various cellular processes like RNA turnover, gene expression, and quality control of RNA transcripts. By acting on KIAA1984, inhibitors in this class can affect the cellular machinery involved in the degradation of specific types of RNA molecules. This is particularly significant because the balance between RNA synthesis and degradation is tightly regulated to maintain cellular homeostasis and proper gene expression profiles. As KIAA1984 is highly conserved across species, its inhibitors have attracted attention due to their potential to influence fundamental biological processes related to RNA surveillance and degradation pathways.
From a biochemical perspective, KIAA1984 inhibitors typically work by binding to key catalytic domains of the protein, such as the PIN domain or the exonuclease domains, which are involved in the endonucleolytic or exonucleolytic cleavage of RNA substrates. This interaction disrupts the normal enzymatic function of KIAA1984, leading to altered RNA processing and an accumulation of specific RNA substrates within the cell. Studying the chemical structures of these inhibitors provides insight into the critical motifs required for their inhibitory activity. Many of these inhibitors exhibit selectivity, which is vital for minimizing off-target effects on other RNA-processing enzymes. The modulation of RNA turnover via KIAA1984 inhibition also creates opportunities for studying gene regulation mechanisms, as RNA stability is a key determinant of how genes are expressed and maintained at the post-transcriptional level. Understanding the chemical interactions between KIAA1984 and its inhibitors can reveal deeper insights into cellular RNA management and control.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $49.00 $367.00 $2030.00 | 18 | |
This compound binds to cereblon, affecting its substrate specificity, which can alter the ubiquitination and subsequent degradation of certain proteins. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $98.00 $140.00 $306.00 $459.00 $1224.00 $1958.00 | 1 | |
Similar to lenalidomide, pomalidomide associates with cereblon, modulating its activity and potentially affecting downstream signaling. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Thalidomide is known to bind to cereblon, changing its interaction with various proteins and influencing downstream effects. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that can increase the levels of ubiquitinated proteins, indirectly affecting the function of cereblon. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $40.00 | ||
Another proteasome inhibitor that can lead to an accumulation of cereblon's substrates, indirectly modulating its function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A peptide aldehyde that inhibits the proteasome, potentially increasing the substrate load on cereblon. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
An inhibitor of the NEDD8-activating enzyme, which can disrupt the neddylation pathway that affects ubiquitin ligase activity. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
A specific inhibitor of the proteasome that can indirectly affect cereblon function by stabilizing its substrates. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
A proteasome inhibitor that can lead to an accumulation of proteins targeted by cereblon. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
This compound affects the lysosomal degradation pathway, which can influence the turnover of proteins modulated by cereblon. | ||||||